Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease

Medical University of Vienna, Department of Internal Medicine III, Division Gastroenterology and Hepatology, Vienna

Bugát Pál Kórház, Gasztroenterológiai osztály, Gyöngyös

Békés Megyei Központi Kórház Dr. Réthy Pál Tagkórháza, Békéscsaba

Klinikum Klagenfurt am Wörthersee, Klagenfurt

Istituto Clinico Humanitas, Rozzano

Gastro Center of Maryland, Columbia

John Hopkins Gastroenterology and Hepatology Services at the Green Spring Station Clinic, Baltimore

McGuire DVAMC, Richmond

Center for Interventional Endoscopy - Florida Hospital, Orlando

University of Miami Crohn's and Colitis Center, Miami

University of South Florida South Tampa Campus, Tampa

Gastro One, Germantown

CHU Grenoble Alpes - Hopital Michallon (main office), La Tronche

University of Louisville Clinical Trials Unit, Louisville

CHU Nancy - Hopital de Brabois, Vandœuvre-lès-Nancy

Northwestern University Feinberg School of Medicine, Chicago

DHAT Research Institute, Garland

Texas Clinical Research Institute, Arlington

Texas Digestive Disease Consultants, Southlake

CHU de Rennes - Hôpital Pontchaillou (main office), Rennes

Vanderbilt University Medical Center - IBD Clinic, Nashville

Universitaire Ziekenhuizen Leuven, Leuven

Mount Sinai Hospital, Toronto

Toronto Digestive Disease Associates Inc., Toronto

Universitätsklinikum Carl Gustav Carus an der TU Dresden, Dresden

Universitatsklinkum Jena, Jena

Royal Devon and Exeter Hospital, Department of Gastroenterology, Exeter